April 5, 2023

We are pleased to announce our investment in Marcyrl Pharmaceutical Industries !

London, Paris, and Cairo, April 4th, 2023 – Marcyrl Pharmaceutical Industries (“Marcyrl”), a leading Egyptian pharmaceuticals manufacturer focused on specialty generics, today announced a new investment aimed at accelerating its ambition to drive greater access to critical care drugs across Africa. The significant minority investment from Development Partners International (“DPI”) and Amethis, will further institutionalise...
Read More